| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 5 |
| 1 | LAMIVUDINE ORAL | 5 |
| 2 | NEVIRAPINE | 5 |
| 3 | QUININE | 5 |
| 4 | ZIDOVUDINE | 5 |
| 5 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 2 |
| 6 | DOXYCYCLINE HYCLATE | 2 |
| 7 | EFAVIRENZ | 2 |
| 8 | INFLIXIMAB | 2 |
| 9 | METHOTREXATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARTEMETHER AND LUMEFANTRINE | 1 | 0.0051 |
| 1 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 2 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 2 | 0.0009 |
| 3 | QUININE | 5 | 0.0006 |
| 4 | NEVIRAPINE | 5 | 0.0006 |
| 5 | ZIDOVUDINE | 5 | 0.0005 |
| 6 | IDURSULFASE | 1 | 0.0003 |
| 7 | LAMIVUDINE | 5 | 0.0002 |
| 8 | EFAVIRENZ | 2 | 0.0002 |
| 9 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 3 | 0.0003 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0002 |
| 2 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |
| 6 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 7 | General Anesthetic [EPC] | 1 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 1 | 0.0000 |